Pharma Journalist - Page 112 of 834 -

Solid Biosciences Receives FDA IND Clearance for Dual Route Gene Therapy in Friedreich’s Ataxia

FDA Granted Priority Review to Dizal’s Sunvozertinib New Drug Application

Amgen’s IMDYLLTRA Granted Conditional Approval for Small Cell Lung Cancer in UK

Ferring Receives U.S. FDA Approval for REBYOTA (fecal microbiota, live-jslm) – A Novel First-in-Class Microbiota-Based Live Biotherapeutic

argenx Enters Into Agreement To Acquire Priority Review Voucher

Kintara Therapeutics Granted Fast Track Designation from FDA for REM-001 for Cutaneous Metastatic Breast Cancer

Aldeyra Therapeutics Submits New Drug Application to the FDA for Reproxalap for the Treatment of Signs and Symptoms of Dry Eye Disease

Clinigen adds pharmacovigilance capabilities with acquisition of Drug Safety Navigator

Envisagenics Announces Research Collaboration with Bristol Myers Squibb

AstraZeneca to Acquire Neogene Therapeutics, Accelerating Ambition in Oncology Cell Therapy

City of Hope scientists develop new potential treatment for brain tumors

European Commission Grants Expanded Marketing Authorization for Gilead’s Biktarvy for the Treatment of HIV in Pediatric Populations

ANI Pharmaceuticals Announces the FDA Approval and Launch of Fluoxetine Oral Solution USP